13-1-4　ⓔ文献

  1. Chung BH, Lam ST, et al: Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan–like phenotypes. Am J Med Genet A, 2009; 149: 1452–1459.

  2. Malfait F, Wenstrup RJ, et al: Clinical and genetic aspects of Ehlers–Danlos syndrome, classic type. Genet Med, 2010; 12:597–605.

  3. Bashford–Rogers RJM, Smith KGC, et al: Antibody repertoire analysis in polygenic autoimmune diseases. Immunology, 2018; 155: 3–17.

  4. Okada Y, Wu D, et al: Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature, 2014; 506: 376–381.

  5. Cui Y, Sheng Y, et al: Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun, 2013; 41: 25–33.

  6. Li Y, Zhang K, et al: A genome–wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren’s syndrome at 7q11.23. Nat Genet, 2013; 45: 1361–1365.

  7. Brown MA: Genetics of ankylosing spondylitis. Curr Opin Rheumatol, 2010; 22: 126–132.

  8. Riches L, Wright AF, et al: Recent insights into the pathogenesis of hyperuricaemia and gout. Hum Mol Genet, 2009; 18: R177–R184.

  9. Onouchi Y: Molecular genetics of Kawasaki disease. Pediatr Res, 2009; 65: 46R–54R.

  10. Prahalad S, Glass DN: A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatr Rheumatol Online J, 2008; 6: 11.

  11. Assassi S, Radstake TR, et al: Genetics of scleroderma: implications for personalized medicine? BMC Med, 2013; 11: 9.